Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom-Reference-Cited by-同舟云学术

Cost-effectiveness evaluation of quadrivalent influenza vaccines for seasonal influenza prevention: a dynamic modeling study of Canada and the United Kingdom

Published:2015-10-27 Issue:1 Volume:15 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Thommes Edward W.,Ismaila Afisi,Chit Ayman,Meier Genevieve,Bauch Christopher T.

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-015-1193-4.pdf

Reference58 articles.

1. World Health Organization position paper on influenza vaccines. Wkly Epidemiol Record 2005; 33, 279–287.

2. Ambrose CS, Levin MJ. The rationale for quadrivalent influenza vaccines. Hum Vaccin Immunother. 2012;8(1):81–8. doi: 10.4161/hv.8.1.17623 .

3. Daley AJ, Nallusamy R, Isaacs D. Comparison of influenza A and influenza B virus infection in hospitalized children. J Paediatr Child Health. 2000;36(4):332–5.

4. Hite LK, Glezen WP, Demmler GJ, Munoz FM. Medically attended pediatric influenza during the resurgence of the Victoria lineage of influenza B virus. Int J Infect Dis. 2007;11(1):40–7. doi: 10.1016/j.ijid.2005.10.008 .

5. Ng S, Cowling BJ, Fang VJ, Chan KH, Ip DKM, Cheng CKY, et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis. 2010;50(5):707–14. doi: 10.1086/650458 .

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and Older;Vaccines;2024-08-22

2. Immunogenicity and safety of quadrivalent inactivated influenza vaccine in children aged 6 to 35 months: A systematic review and meta-analysis;Human Vaccines & Immunotherapeutics;2023-08

3. Cost-Effectiveness and Health Impacts of Different Influenza Vaccination Strategies for Children in China;American Journal of Preventive Medicine;2023-07

4. Review of Vaccination Recommendations in Guidelines for Non-Communicable Diseases with Highest Global Disease Burden among Adults 75 Years Old and Above;Vaccines;2023-06-08

5. Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review;Value in Health;2023-05